 |
|
PalindromX secures £100,000
PalindromX, the developer of a patented technology that facilitates more accurate diagnosis by improving the performance of conventional blood tests, has secured a six-figure investment to continue its proof of concept work.
The company raised £100,000 from Merseyside Special Investment Fund’s (MSIF) Liverpool Ventures Seed Fund. The proceeds will be used to take the company’s analytical methodology to the next phase of development where its viability and potential market demand are assessed.
MSIF was advised on the terms of its investment by Weightmans, led by partner and head of corporate John Schorah, assistant solicitor Lynne Rathbone and associate Sean Crotty.
Schorah said Weightmans has worked with MSIF on several of its investments. “On this occasion, it provided funding to PalindromX so as to assist with its valuable research and development of improved sensitivity for immunoassay techniques.”
People also read ... |
Related Articles |
Interesting links
Other Sector Watch
- Investment veteran airs fears over UK biotech Oct 21 2008
- Talking rubbish Jul 28 2008
- Crisis?– what crisis? Jul 01 2008
- Let the
drilling begin
May 13 2008 - Bargains on the high street
Mar 13 2008
M&A News
- YFM backs training programme for golfers Dec 04 2008
- Biomonitor buys Neutekbio gene technology firm Dec 04 2008
- UK top EU dealmaker by volume Dec 03 2008
- Marfin Investment buys Flight Ambulance stake Dec 03 2008
- Corporates idealistic about M&A Dec 02 2008
Special Offers
- 2008 AIM Guide: Jul 17 2007
- Growth Company Investor Magazine: Jul 17 2007
- Cash Shells 2007 - Research report Jul 17 2007
- Venture Capital Trusts Jul 04 2007
M&A Deals
- BTG buys Protherics Dec 04 2008
- Umeco announces Italian acquisition Dec 04 2008
- Sunkar signs Temir subsidiary deal Dec 03 2008
- Destiny gets £4.8m injection Dec 03 2008
- IMS Maxims acquires CSW assets Dec 02 2008
Business Diary
- M&A Expanding internationally 27th November
- Rosenblatt New Energy Awards 2009 25th February